Subscribe to receive our monthly print or digital publication
Join our 70,000+ readers. And yes, it's completely free.
- Sponsored Content
Gene Editing: A Step Change in Biopharmaceutical ManufacturingGene Editing: A Step Change in Biopharmaceutical Manufacturing
Jamie Freeman
August 1, 2019
1 Min Read
Sponsored by Horizon Discovery
The natural characteristics of Chinese hamster ovary (CHO) cells have contributed to their use as the dominant expression platform in biomanufacturing. To increase the capabilities of these host systems, fundamental improvements to the CHO cell line are needed, which is where we believe that gene editing can offer a step change in biopharmaceutical manufacturing.
Fill out the form below to read the complete technology review now.
You May Also Like
Mar 18 - Mar 21, 2025
Mar 18 - Mar 21, 2025
SLASH TIME FROM BENCH TO BEDSIDE: Cutting-edge biomanufacturing for mAbs, vaccines, and advanced therapies. Bright ideas, bold science, and big innovations—delivering efficiency, precision, and quality through every phase of bioprocessing.
Learn MoreInnovative Technology
Sponsored Content
